ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant)
Pharmaceutical ManufacturingCalifornia, United States51-200 Employees
ISTA Pharmaceuticals, based in Irvine, California, was a specialty pharmaceutical company focused on developing, marketing, and selling eye-care products in the United States and Puerto Rico. Its offerings addressed ocular inflammation and pain, glaucoma, dry eye, and ocular allergies, supported by a field sales force calling on ophthalmologists, optometrists, and allergists, and it had an emerging allergy drug franchise. The company operated as a mid-sized player within the pharmaceutical manufacturing industry. Its four principal products were Bromday for postoperative inflammation and ocular pain after cataract surgery, Bepreve for ocular itching due to allergic conjunctivitis, Istalol for glaucoma, and Vitrase as a spreading agent. In 2012, ISTA was acquired by Bausch + Lomb and began operating within its Pharmaceutical business, with Bausch + Lomb later being acquired by Valeant. The ISTA legacy is tied to the Bausch + Lomb platform, and its information is cataloged on the Bausch site.
1-888-653-2347 
support@leadiq.com 
